IVF 8-K: SEC filing
INVO Fertility, Inc.
Filed with the SEC on · accession 0001493152-26-052109
IVF filed a 8-K (current report) with the SEC on Nov 16, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -5.4% by the first close after the filing.
Summary of the filing
INVO Fertility, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
Key details
How IVF stock reacted
Close before
$2.60
Nov 13, 2026
First close after
-5.36%
$2.46
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IVF, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IVF?
Click hereFrequently asked questions
What did IVF file with the SEC on Nov 16, 2026?
IVF filed a 8-K (SEC filing). INVO Fertility, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did IVF stock react to this filing?
IVF closed at $2.60 before the filing and $2.46 on Nov 16, 2026 (-5.36%).
Other IVF SEC filings
- 10-Q · SEC filingNov 16, 2026
- 8-K · Stock splitNov 4, 2026
- SCHEDULE 13G/A · SEC filingOct 9, 2026
- 8-K · Secondary offeringAug 28, 2026
- 8-K · SEC filingAug 17, 2026
- 10-Q · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 424B3 · Secondary offeringAug 7, 2026
- 8-K · Material agreementJul 24, 2026
- S-1 · AcquisitionJul 24, 2026
Get alerts when IVF files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days